Detalles de la búsqueda
1.
Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?
Health Econ;
31 Suppl 1: 10-24, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35989520
2.
Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure.
Value Health;
24(10): 1435-1445, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593166
3.
Impact of hospitalisation on health-related quality of life in patients with chronic heart failure.
Health Qual Life Outcomes;
18(1): 262, 2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746842
4.
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis.
Value Health;
21(2): 193-202, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477401
5.
The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios.
BMC Fam Pract;
19(1): 31, 2018 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454331
6.
Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.
Rheumatology (Oxford);
56(5): 777-786, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087832
7.
A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.
Value Health;
20(8): 1041-1047, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28964435
8.
Cardiovascular risk factor management in patients with RA compared to matched non-RA patients.
Rheumatology (Oxford);
55(5): 809-16, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26705329
9.
Determining the impact of modeling additional sources of uncertainty in value-of-information analysis.
Value Health;
18(1): 100-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595240
10.
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
J Allergy Clin Immunol;
132(2): 353-60.e2, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23651609
11.
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation.
Expert Rev Pharmacoecon Outcomes Res;
24(4): 551-557, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400836
12.
Benefits of a digital health technology for older nursing home residents. A de-novo cost-effectiveness model for digital health technologies to aid in the assessment of toileting and containment care needs.
PLoS One;
19(1): e0295846, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166006
13.
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.
Eur Respir J;
41(3): 556-64, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22700844
14.
Economic evaluation alongside a single RCT of an integrative psychotherapeutic nursing home programme.
BMC Health Serv Res;
13: 370, 2013 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24079838
15.
Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness Analysis.
JMIR Cardio;
6(2): e31302, 2022 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35925670
16.
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.
PLoS One;
17(1): e0261940, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089941
17.
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
Drugs Real World Outcomes;
9(2): 275-285, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314962
18.
Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
Value Health;
14(8): 1039-47, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22152172
19.
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.
Crit Care;
14(6): R195, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21040558
20.
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations.
Eur J Health Econ;
21(1): 153-164, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31541309